mesembrenone has been researched along with gsk 256066 in 1 studies
| Studies (mesembrenone) | Trials (mesembrenone) | Recent Studies (post-2010) (mesembrenone) | Studies (gsk 256066) | Trials (gsk 256066) | Recent Studies (post-2010) (gsk 256066) |
|---|---|---|---|---|---|
| 7 | 0 | 7 | 15 | 0 | 13 |
| Protein | Taxonomy | mesembrenone (IC50) | gsk 256066 (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 2.6333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
1 review(s) available for mesembrenone and gsk 256066
| Article | Year |
|---|---|
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |